316 related articles for article (PubMed ID: 21888294)
1. [Blood safety in Mexico. Achievements and challenges].
Sánchez-Guerrero SA
Rev Invest Clin; 2011; 63(3):309-13. PubMed ID: 21888294
[No Abstract] [Full Text] [Related]
2. Modeling the risk of an emerging pathogen entering the Canadian blood supply.
Kleinman S; Cameron C; Custer B; Busch M; Katz L; Kralj B; Matheson I; Murphy K; Preiksaitis J; Devine D
Transfusion; 2010 Dec; 50(12):2592-606. PubMed ID: 20553433
[TBL] [Abstract][Full Text] [Related]
3. The revision of the European blood directives: A major challenge for transfusion medicine.
Folléa G; Aranko K;
Transfus Clin Biol; 2015 Aug; 22(3):141-7. PubMed ID: 26056039
[TBL] [Abstract][Full Text] [Related]
4. [Blood donor hemovigilance: impact for donor and recipient safety].
Hauser L; Beyloune A; Simonet M; Bierling P
Transfus Clin Biol; 2013 May; 20(2):99-103. PubMed ID: 23587614
[TBL] [Abstract][Full Text] [Related]
5. Transposition of the Blood Directive into national law--the perspective of Portugal.
Gonçalves MH; Muon MC; Gonçalves Jd
Transfus Clin Biol; 2005 Feb; 12(1):18-20. PubMed ID: 15814287
[TBL] [Abstract][Full Text] [Related]
6. AABB contributions to plasma safety.
Triulzi DJ
Transfusion; 2012 May; 52 Suppl 1():5S-8S. PubMed ID: 22578373
[No Abstract] [Full Text] [Related]
7. [Seventeen years of haemovigilance in France: assessment and outlook].
Carlier M; Vo Mai MP; Fauveau L; Ounnoughene N; Sandid I; Renaudier P
Transfus Clin Biol; 2011 Apr; 18(2):140-50. PubMed ID: 21474356
[TBL] [Abstract][Full Text] [Related]
8. Moving on from voluntary non-remunerated donors: who is the best blood donor?
Allain JP
Br J Haematol; 2011 Sep; 154(6):763-9. PubMed ID: 21539535
[TBL] [Abstract][Full Text] [Related]
9. The safety and availability of blood and tissues--progress and challenges.
Goodman JL
N Engl J Med; 2004 Aug; 351(8):819-22. PubMed ID: 15317896
[No Abstract] [Full Text] [Related]
10. Advancing risk assessment for emerging infectious diseases for blood and blood products: proceedings of a public workshop.
Gallagher LM; Ganz PR; Yang H; Kessler DA; O'Brien SF; Custer BS; Busch MP; Dodd RY; Stramer SL; Walderhaug MO; Forshee RA; Williams AE; Epstein JS; Anderson SA
Transfusion; 2013 Feb; 53(2):455-63. PubMed ID: 22845334
[No Abstract] [Full Text] [Related]
11. [Blood transfusion and supply chain management safety].
Quaranta JF; Caldani C; Cabaud JJ; Chavarin P; Rochette-Eribon S
Presse Med; 2015 Feb; 44(2):214-20. PubMed ID: 25578550
[TBL] [Abstract][Full Text] [Related]
12. Toward universal pathogen reduction of the blood supply (Conference Report, p. 3002).
Marks P; Verdun N
Transfusion; 2019 Sep; 59(9):3026-3028. PubMed ID: 31218709
[No Abstract] [Full Text] [Related]
13. [Technological evolutions in blood donation screening and their impact on the residual risk].
Barlet V
Transfus Clin Biol; 2011 Apr; 18(2):292-301. PubMed ID: 21466969
[TBL] [Abstract][Full Text] [Related]
14. [Virologic safety of donor blood after NAT testing].
Harritshøj LH; Erikstrup C; Ullum H
Ugeskr Laeger; 2012 Mar; 174(12):796. PubMed ID: 22433553
[No Abstract] [Full Text] [Related]
15. AIDS and the blood supply: an analysis of law, regulation, and public policy.
Salbu SR
Wash Univ Law Q; 1996; 74(4):913-80. PubMed ID: 16273697
[No Abstract] [Full Text] [Related]
16. In the NAT era, is routine lookback to recipients still required when donors seroconvert for HIV infection?
Vishram B; Reynolds C; Brailsford SR; Hewitt P
Vox Sang; 2019 May; 114(4):394-396. PubMed ID: 30820949
[TBL] [Abstract][Full Text] [Related]
17. Safety improving by complementary serological and molecular testing combined with pathogen reduction of the donated blood in window period.
Balint B; Vucetic D; Todorovic-Balint M; Borovcanin N; Jovanovic-Cupic S; Mandusic V
Transfus Apher Sci; 2013 Aug; 49(1):103-4. PubMed ID: 23820432
[No Abstract] [Full Text] [Related]
18. Transposing the E. E. U. Blood Directive into national law. Perspective of Slovenia.
Potocnik M
Transfus Clin Biol; 2005 Feb; 12(1):21-4. PubMed ID: 15814288
[TBL] [Abstract][Full Text] [Related]
19. Proceedings of a consensus conference: Risk-Based Decision Making for Blood Safety.
Leach Bennett J; Blajchman MA; Delage G; Fearon M; Devine D
Transfus Med Rev; 2011 Oct; 25(4):267-92. PubMed ID: 21763103
[TBL] [Abstract][Full Text] [Related]
20. Risk-based decision-making for blood safety: preliminary report of a consensus conference.
Stein J; Besley J; Brook C; Hamill M; Klein E; Krewski D; Murphy G; Richardson M; Sirna J; Skinner M; Steiner R; van Aken P; Devine D
Vox Sang; 2011 Nov; 101(4):277-81. PubMed ID: 21781125
[No Abstract] [Full Text] [Related]
[Next] [New Search]
